Leave with a usable plan
Confirm her Heart Story, medicines, clinical follow-up windows, equipment, language needs and verified contacts. Ask her to explain the warning signs and next step in her own words.
Your hospital’s name. A continuing relationship after delivery.
The HEART RESERVE Concierge Advocate is a proposed hospital-branded service, with a health-plan funding option, designed to reduce avoidable post-delivery complications and their cost—combining patient education, warning-sign recognition and accountable clinical follow-up.
Founded by Lisa Zahakos, RPA-C. Product demonstration and licensing proposal. Clinical effectiveness and savings have not been established; patient care requires an operating hospital service.
of pregnancy-related deaths in the cited 2022 MMRC data occurred 1–365 days postpartum.
occurred 43–365 days postpartum. The relationship must extend beyond a six-week visit.
Include both cesarean and vaginal births. Mental health, cardiovascular conditions, infection, bleeding, clots and hypertensive disorders belong in the care model.
CDC MMRC 2022 data, summarized by the American Hospital Association. These are shares of pregnancy-related deaths, not risks among all women or figures limited to after discharge. The program’s effect remains to be tested.
The core hospital service
Confirm her Heart Story, medicines, clinical follow-up windows, equipment, language needs and verified contacts. Ask her to explain the warning signs and next step in her own words.
Short check-ins collect symptoms, relevant home readings and barriers. Hospital-approved rules flag reported warning signs. A normal reading must never cancel a concerning symptom.
Urgent instructions interrupt routine coaching. The woman sees what to do now; the staffed team receives concerns through an agreed pathway. Emergencies never wait in a routine inbox.
Show the owner, due date, barrier and evidence for every action. Separate received, reviewed, scheduled and completed. Confirm the plan, medication access and handoff into continuing care.
Read the detailed postpartum monitoring workflow and evidence → · CDC urgent maternal warning signs ↗
Named clinical ownership, coverage hours, backup arrangements, acknowledgement and overdue escalation are required. This preview sends no clinical alerts and has no monitoring team.
Teach → understand → act → review
A short explanation, one achievable action, a check of understanding and a place in her continuing Heart Story. Goals adapt to pregnancy, recovery, feeding, symptoms, resources and the clinician’s plan.
Practical meals, nutrition questions and food-access support.
Recovery-appropriate movement and gradual return to function.
Smoking and vaping education with routes to cessation support.
Realistic rest and support; breathing difficulty is a clinical concern.
Context, nutrition and strength; progress beyond the scale.
Explain available results and record the clinician’s next step.
Connect gestational-diabetes history to planned testing and care.
Teach measurement technique, the prescribed plan and when to seek help.
Based on the American Heart Association’s Life’s Essential 8. Independent program; no AHA endorsement or use of its licensed scoring tool is implied. Education complements timely clinical treatment.
A dedicated continuing-care arm
Connect the prescribing plan, body changes and everyday function to pregnancy history, midlife, heart-health results and completed follow-up.
Plain-language GLP-1 education; clinician-created medication, nutrition and activity plans; weight and waist trends; strength and function notes; symptoms, access barriers and progress summaries. Body-composition estimates require a validated method and clear source labels.
Prior preeclampsia or gestational diabetes, current pregnancy or breastfeeding context, hormones and contraception, BP, available lipid and glucose results, symptoms and the next clinical review. The prescriber retains medication decisions.
Reference: Dr. Rocío Salas-Whalen’s WeightlessAI published feature description. Its listing advertises GLP-1 education, body-composition tracking, progress views and clinician-created plans for clinic-invited patients. This is a comparison, not an integration, license or endorsement. HEART RESERVE uses original content and separately agreed technology.
Open Weight, Strength & GLP-1 →Build on Emagine’s existing platform
Emagine publicly offers Aria’s maternal conversations, onboarding and check-ins; The Journey’s patient tracking, alerts, messaging and clinician dashboard; and white-label branding. The scope available under a hospital license must be demonstrated and priced. Published capability does not establish HEART RESERVE’s efficacy.
| Area | What the combined hospital product must deliver | Implementation |
|---|---|---|
| Maternal companion | Reuse Aria and The Journey’s education, check-ins and patient/clinician experience. | Verify existing licensed scope. |
| Warning signs and care response | Approved postpartum rules, symptom-first escalation, coverage and failed-delivery handling. | Configure, integrate and clinically validate. |
| Heart Story and lab capture | Pregnancy history; photo/PDF extraction for patient verification; original reports, dates, units, conflicts and corrections. | Prototype exists; production extraction and data exchange need development. |
| Readings and cardiac context | BP, pulse, weight, waist, sleep and activity; available glucose/CGM, ECG and clinician-selected labs including ApoB, Lp(a), kidney tests and BNP/NT-proBNP. | Validate each interface and use. No universal test panel or diagnosis from one number. |
| Teaching and prevention | Life’s Essential 8, teach-back, original reviewed lessons and Lisa-approved recordings linked to one action. | Configure content, review and update process. |
| Midlife and metabolic care | Hormone route/dose/dates, cycle and contraception context; Weight, Strength & GLP-1 pathway. | Expand beyond maternal scope under agreed rights. |
| Advocacy and completion | Patient-approved messages, visit passport, action owner/date/barrier/status, consented helper sharing and completed handoffs. | Build verified delivery, review and completion states. |
| Hospital operations | Hospital brand, approved contacts/pathways, staff roles, organization-separated records, audit trail, response queue and quality/cost dashboard. | Contract, configure, integrate and test. |
Sources: Aria AI, The Journey platform, Emagine white-label offering. Public descriptions reviewed October 22, 2026; no source-code or signed-contract audit.
The proposed funding model
HEART RESERVE would license the postpartum education and advocacy program, with the goal of fewer avoidable complications and lower total medical spending. A health plan could purchase it for an agreed group of members; eligible women would use it under that benefit’s terms.
Agree eligibility, funding, member access, clinical service expectations, claims evaluation and renewal criteria. A Medicaid managed-care plan or commercial insurer is a proposed buyer.
Enroll members at discharge, approve pathways, staff the response and document completed follow-up. Funding must include the people and equipment needed to deliver care.
Provide the licensed curriculum, advocacy workflows, software, onboarding and reporting under defined ownership and service agreements. AI capabilities require separate implementation and validation.
Receives understandable education, help with barriers, a clear route to care and a continuing Heart Story. No charge per symptom report or warning-sign question is proposed.
| Program | Relevant overlap | Published buyer evidence |
|---|---|---|
| Maven Clinic ↗ | Maternity and family support, education and access to providers. | BCBSIL identifies a Maven contract on a member-benefit page. Availability depends on the member’s plan. |
| Babyscripts ↗ | Pregnancy and postpartum remote monitoring and care management. | Its maternity program explicitly serves clinicians and payers. |
| Hello Heart ↗ | Cardiovascular tracking, medication support and Nia, an AI education assistant. | Offers health-plan programs and describes fees tied to program effectiveness. |
These examples establish market overlap. They do not establish HEART RESERVE’s effectiveness, payer coverage, a partnership or access to another company’s technology. HEART RESERVE must demonstrate a useful advantage within the buyer’s existing services.
Recommended proposal: one plan, one hospital service and an initial hypertensive-pregnancy cohort. Negotiate a fixed pilot budget and a fee per enrolled 90-day episode, or an active-member monthly fee. Define clinical response, devices, enrollment, continuation, reporting and the royalty paid for HEART RESERVE’s licensed contribution. These are proposed terms, not published market rates or confirmed reimbursement.
Evaluate timely follow-up, medication access, understanding, response time, safety, staff effort, emergency visits and readmissions. Use an agreed comparator and risk adjustment for cost analysis. A small feasibility pilot establishes whether the service can operate; a larger evaluation is needed to make reliable savings claims.
A negotiated program benefit and payment for qualifying clinician services are separate arrangements. CMS describes Medicare remote patient monitoring; those requirements do not establish Medicaid or commercial coverage for this app. Insurance funding, billing eligibility and all clinical services remain unconfirmed.
Scope the proposed pilot →The hospital’s business case
Earlier appropriate treatment, fewer avoidable severe episodes, more completed follow-up and less repetitive administrative work. Education supports understanding and prevention; it is not a substitute for access to care.
Emergency visits, readmissions, severity, time to clinical contact, comprehension, follow-up completion, staff minutes and total operating cost. Appropriate urgent visits may increase when problems are recognized earlier.
Hospital cash savings, payer savings and released staff capacity are separate outcomes. Finance must account for payment arrangements, avoidable costs and any lost reimbursement. A reduction in hospital charges is not a saving estimate.
Editable planning scenario · no forecast
Enter hospital-approved assumptions. All amounts are US dollars. The $100,000 starting budget is Lisa’s proposed 12-month pilot envelope, not a vendor quote or an agreed price.
Net impact = avoided episodes × net hospital value per episode + verified other benefit − program cost − additional care cost. Do not count the same benefit twice. This demonstration does not access hospital finances or predict outcomes.
What the hospital licenses
Hospital-branded patient experience; approved education and care pathways; clinician operations and reporting; onboarding, training, support and agreed integrations. Price implementation, annual platform/program licensing, participant use and staffed clinical services explicitly.
Original curriculum, program design, Heart Story and advocacy workflows, and ongoing content stewardship. Negotiate an initial development fee plus recurring royalties for defined use—including hospital rebrands and sublicenses.
Suggested royalty unit: each enrolled participant episode, with a defined duration and renewal rule. An active-participant-month is an alternative. Define duplicate accounts, refunds, reporting, audit rights and an annual minimum. Fees should not discourage symptom reporting or necessary care.
Each party retains its existing intellectual property; new-work ownership, branding, permitted rebranding, sublicensing, data export and exit rights need a written agreement. Emagine’s white-label offer alone does not establish HEART RESERVE’s resale rights or a royalty entitlement.
Proposed health-plan funding with one hospital service, 50 postpartum mothers, within a proposed $100,000 / 12-month project. Begin with a clinically approved hypertensive-pregnancy pathway and overlapping cardiac, diabetes and psychosocial needs. Set recruitment and follow-up dates so each participant’s care window is explicit. Measure early follow-up and 30- and 90-day outcomes; plan ongoing first-year care and later expansion.
Agree baseline/comparator, staffing, data access, total costs and go/no-go criteria before enrollment. A 100-person feasibility pilot can evaluate workflow, understanding, access and cost; it cannot establish a mortality reduction or reliably prove savings from rare events.